Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity

MLA

Satvinder Mudan, et al. Enhanced Effect of Checkpoint Inhibitors When given after or Together with IMM-101: Significant Responses in Four Advanced Melanoma Patients with No Additional Major Toxicity. Aug. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....041ca090974d468ad8bd9cfbc591f666&authtype=sso&custid=ns315887.

APA

Satvinder Mudan, Angus G. Dalgleish, & Alberto Fusi. (2018). Enhanced effect of checkpoint inhibitors when given after or together with IMM-101: significant responses in four advanced melanoma patients with no additional major toxicity.

Chicago

Satvinder Mudan, Angus G. Dalgleish, and Alberto Fusi. 2018. “Enhanced Effect of Checkpoint Inhibitors When given after or Together with IMM-101: Significant Responses in Four Advanced Melanoma Patients with No Additional Major Toxicity,” August. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....041ca090974d468ad8bd9cfbc591f666&authtype=sso&custid=ns315887.